SHOULD closure of a patent ductus arteriosus with reversal of flow be attempted? If so, how can the high surgical mortality hitherto reported 1–3 be reduced? An attempt is made to answer these ...

Patent Ductus arteriosus is the second commonest congenital birth defect of the heart and can cause heart failure; however majority of these defect close spontaneously after birth. Patent Ductus ...

Patent ductus arteriosus (PDA) is a congenital cardiac defect that occurs when the ductus arteriosus fails to close. The result is a persistent communication between the aorta and pulmonary artery, ...

ANGIOCARDIOGRAPHY—contrast visualization of the heart and great vessels — was first made a practical procedure by Robb and Steinberg 1 in 1938. In subsequent reports these authors have described in ...

Please provide your email address to receive an email when new articles are posted on . NUSA DUA, Indonesia — A study presented here showed birth weight, ventilation duration, sepsis and patent ductus ...

Active treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants within the first 2 weeks of life was associated with worse outcomes than expectant management.

Cyclo-oxygenase inhibitors like Indomethacin or Ibuprofen are used to close the PDA during the 2nd week of life. 1) INDOMETHACIN Indomethacin is a non-steroidal anti-inflammatory medication. It ...

Patent ductus arteriosus refers to a heart problem that affects babies soon after they are born. In this medical condition, there is an abnormal flow of blood between the two of the major arteries ...